Oh no. I live in the employed, eternal now
🙂
Here, rad onc salary is
up 12 to 33% over the last 7-8 years per MGMA and Doximity.
Here, rad onc reimbursement is
down 25% over the last 12 years.
This is very suggestive that the significant cuts looming to our professional reimbursement next year mean we are all about to, yet again, get another annual pay raise. Just like the one we got this year and last year. (By "we" I mean the "median we." We's mileage may vary.)
And that should make all of us employed rad oncs very happy. If ROCR stabilizes things, past financial history pretty much indicates: our salaries should stagnate, or go down. We should all hate ROCR for that reason alone... it threatens to stabilize reimbursement, threatening our annual significant salary increases which, again, MGMA and Doximity
prove have been happening.
View attachment 408039View attachment 408040
View attachment 408044View attachment 408045